Eribulin Mesylate and Gengraf
Determining the interaction of Eribulin Mesylate and Gengraf and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Consumer information for this minor interaction is not currently available. Some minor drug interactions may not be clinically relevant in all patients. Minor drug interactions do not usually cause harm or require a change in therapy. However, your healthcare provider can determine if adjustments to your medications are needed.
Professional:The concomitant use of eribulin with drugs that inhibit hepatic transport proteins (e.g., organic anion-transporting proteins or multidrug resistant proteins) may theoretically increase its plasma concentrations. Up to 70% of an eribulin dose is eliminated through biliary excretion. Clinical data have not been reported.
- Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
Generic Name: eribulin
Brand name: Halaven
Synonyms: Eribulin, EriBULin
Generic Name: cyclosporine
Brand name: Gengraf, Neoral, Sandimmune, Sandimmune
Synonyms: Gengraf (Capsules, Modified)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Eribulin Mesylate-Gengraf (Cyclosporine Capsules, Modified)
- Eribulin Mesylate-Gengraf (Cyclosporine Oral Solution, Modified)
- Eribulin Mesylate-Gengraf Capsules
- Eribulin Mesylate-Gengraf Oral
- Eribulin Mesylate-Gengraf Oral Solution
- Eribulin Mesylate-Genicin
- Gengraf-Erivedge
- Gengraf-Erleada
- Gengraf-Erlotinib
- Gengraf-Erlotinib Tablets
- Gengraf-Errin
- Gengraf-Ertapenem